Latest News

Boehringer Ingelheim plans 3-year, $84M expansion in Mexico

Boehringer Ingelheim intends to make a significant investment in its three manufacturing sites in Mexico in the next three years, starting with its site...

ElevateBio names AlloVir as its first portfolio company

A company set up to take biomedical research from academia and build companies around it has revealed its first portfolio company. ElevateBio, a Cambridge, Massachusetts-based...

More

Boehringer Ingelheim plans 3-year, $84M expansion in Mexico

Boehringer Ingelheim intends to make a significant investment in its three manufacturing sites in Mexico in the next three years, starting with its site...

ElevateBio names AlloVir as its first portfolio company

A company set up to take biomedical research from academia and build companies around it has revealed its first portfolio company. ElevateBio, a Cambridge, Massachusetts-based...

Novartis CEO says Zolgensma won’t cost anywhere near the $4M to $5M once quoted

Novartis has said its forthcoming spinal muscular atrophy gene therapy could be cost-effective at a price of up to $5 million, but now the...

MIT researcher alleged to have copied antibody research Otsuka later acquired evaluating potential legal...

Last year, Japanese drugmaker Otsuka Pharmaceutical paid $430 million to acquire Waltham, Massachusetts-based Visterra, a firm that combines computational and experimental technologies to develop...

J&J’s Invokana closes in on badly needed kidney disease nod with FDA ‘priority’ boost

When it comes to Invokana sales, Johnson & Johnson needs a way to stop the bleeding. And it just got one step closer to...
0FansLike
65,684FollowersFollow
23,228SubscribersSubscribe

EDITOR PICKS